Evidence map›Paper›PMID 39030554›Full record

ArticleMalaria journal2024

Barriers to the quality delivery of seasonal malaria chemoprevention in Chad and Burkina Faso: a qualitative exploration of caregivers and community distributors' perspectives.

Kévin Lasmi, Kelly Elimian, Laura Donovan, Narcisse Tounaikok, Adama Traoré, Tinne Gils, Christian Rassi, Madeleine Marasciulo, Sol Richardson, Gauthier Tougri and 2 more

Abstract read
In one paragraph

Article in Malaria journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Kévin LasmiDepartment of Global Public Health, Karolinska Institute, Stockholm, Sweden. kevin.lasmi@gmail.com.
Kelly ElimianDepartment of Global Public Health, Karolinska Institute, Stockholm, Sweden.
Laura DonovanMalaria Consortium, London, UK.
Narcisse TounaikokMalaria Consortium, Chad Country Office, N'Djamena, Chad.
Adama TraoréMalaria Consortium, Burkina Faso Country Office, Ouagadougou, Burkina Faso.
Tinne GilsDepartment of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
Christian RassiMalaria Consortium, London, UK.
Madeleine MarasciuloMalaria Consortium US, Raleigh, NC, USA.
Sol RichardsonVanke School of Public Health, Tsinghua University, Beijing, China.
Gauthier TougriProgramme national de lutte contre le paludisme, Ouagadougou, Burkina Faso.
Mahamat Saleh Issakha DiarProgramme national de lutte contre le paludisme, N'Djamena, Chad.
Kevin BakerDepartment of Global Public Health, Karolinska Institute, Stockholm, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRecommended since 2012 by the World Health Organization (WHO), seasonal malaria chemoprevention (SMC) is a community-based intervention to prevent malaria in children in African regions where malaria transmission follows a seasonal pattern. Following the publication of consolidated WHO guidelines for malaria, SMC is expected to reach more children in new geographies in future years. Though SMC has been shown to reduce malaria-related morbidity and mortality, there is potential for quality improvement of the intervention implementation. Assisted by ten quality standards from a framework developed by Malaria Consortium, this paper aims to better understand the quality of SMC implementation and identify potential barriers to quality delivery of SMC.

methodsA qualitative thematic analysis on data collected after the annual SMC rounds implemented in Burkina Faso and Chad in 2019 was conducted. Sixteen focus group discussions conducted with caregivers and community distributors were analysed. Three selected quality standards for SMC delivery; planning and enumeration; community engagement; and administration of SMC medicines provided overarching quality themes under which subthemes were identified.

resultsEight subthemes relating to the three quality standards were identified. Although SMC was well accepted by communities in both settings, common barriers to the quality delivery of SMC were identified including difficulty ensuring adherence to the SMC administration protocol; difficulties reaching mobile populations; concerns around adverse drug reactions; rumours, and concerns about SMC safety; and community distributors' working conditions. Context-specific barriers included: the suboptimal timeliness of the SMC round in Burkina Faso, and the lack of involvement of female caregivers in mobilization activities in Chad.

conclusionIn the context of increased adoption of SMC, this paper provides relevant insights and recommendations for the improved implementation of SMC programmes. These include the integration of strategies addressing communities' concerns around adverse drug reactions, gender-specific mobilization strategies, and attention to community distributors' working conditions. It also highlights the importance and utility of further, robust research on the quality of SMC delivery.

Indexed as

CaregiversChemopreventionMalariaAntimalarialsBurkina FasoChadChild, PreschoolCommunity Health WorkersFemaleFocus GroupsHumansMaleSeasonsAntimalarialsCaregiversCommunity distributorsMalaria preventionQualitative studyQuality of careQuality standardsSeasonal malaria chemoprevention

Identifiers

PMID39030554
PMCPMC11264698

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.